122 related articles for article (PubMed ID: 20690664)
21. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.
Woo HM; Kim KM; Choi MH; Jung BH; Lee J; Kong G; Nam SJ; Kim S; Bai SW; Chung BC
Clin Chim Acta; 2009 Feb; 400(1-2):63-9. PubMed ID: 19010317
[TBL] [Abstract][Full Text] [Related]
22. 1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma.
Zhou J; Xu B; Huang J; Jia X; Xue J; Shi X; Xiao L; Li W
Clin Chim Acta; 2009 Mar; 401(1-2):8-13. PubMed ID: 19056370
[TBL] [Abstract][Full Text] [Related]
23. Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma.
Li Y; Dang TA; Shen J; Perlaky L; Hicks J; Murray J; Meyer W; Chintagumpala M; Lau CC; Man TK
Proteomics; 2006 Jun; 6(11):3426-35. PubMed ID: 16673437
[TBL] [Abstract][Full Text] [Related]
24. [Metabonomic variation of esophageal cancer within different ethnic groups in Xinjiang, China].
Ayxiam H; Ma H; Ilyar S; Zhang LW; Ablizi A; Batur M; Lu XM
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):591-6. PubMed ID: 19954070
[TBL] [Abstract][Full Text] [Related]
25. Analysis of urinary metabolic signatures of early hepatocellular carcinoma recurrence after surgical removal using gas chromatography-mass spectrometry.
Ye G; Zhu B; Yao Z; Yin P; Lu X; Kong H; Fan F; Jiao B; Xu G
J Proteome Res; 2012 Aug; 11(8):4361-72. PubMed ID: 22768978
[TBL] [Abstract][Full Text] [Related]
26. Urinary metabonomic study of lung cancer by a fully automatic hyphenated hydrophilic interaction/RPLC-MS system.
Yang Q; Shi X; Wang Y; Wang W; He H; Lu X; Xu G
J Sep Sci; 2010 Jun; 33(10):1495-503. PubMed ID: 20309903
[TBL] [Abstract][Full Text] [Related]
27. The metabolic fate of red wine and grape juice polyphenols in humans assessed by metabolomics.
van Dorsten FA; Grün CH; van Velzen EJ; Jacobs DM; Draijer R; van Duynhoven JP
Mol Nutr Food Res; 2010 Jul; 54(7):897-908. PubMed ID: 20013882
[TBL] [Abstract][Full Text] [Related]
28. Practical analytical approach for the identification of biomarker candidates in prediabetic state based upon metabonomic study by ultraperformance liquid chromatography coupled to electrospray ionization time-of-flight mass spectrometry.
Tsutsui H; Maeda T; Toyo'oka T; Min JZ; Inagaki S; Higashi T; Kagawa Y
J Proteome Res; 2010 Aug; 9(8):3912-22. PubMed ID: 20557141
[TBL] [Abstract][Full Text] [Related]
29. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
[TBL] [Abstract][Full Text] [Related]
30. Serum levels of TNF-beta and sTNF-R in patients with malignant bone tumours.
Holzer G; Pfandlsteiner T; Blahovec H; Trieb K; Kotz R
Anticancer Res; 2003; 23(3C):3057-9. PubMed ID: 12926161
[TBL] [Abstract][Full Text] [Related]
31. Dynamic metabonomic analysis of BALB/c mice with different outcomes after D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Feng B; Wu S; Lv S; Fang J; Liu F; Li Y; Gao Y; Yan X; Dong F; Wei L
Liver Transpl; 2008 Nov; 14(11):1620-31. PubMed ID: 18975270
[TBL] [Abstract][Full Text] [Related]
32. [Biochemical bone turnover markers in patients with conventional and nonconventional osteosarcoma].
Ambroszkiewicz J; Gajewska J; Klepacka T; Bilska K; Woźniak W; Laskowska-Klita T
Pol Merkur Lekarski; 2006 Oct; 21(124):330-4. PubMed ID: 17205770
[TBL] [Abstract][Full Text] [Related]
33. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
34. Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor.
Barba I; Garcia-Ramírez M; Hernández C; Alonso MA; Masmiquel L; García-Dorado D; Simó R
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4416-21. PubMed ID: 20375324
[TBL] [Abstract][Full Text] [Related]
35. Soluble p185(HER-2) in patients with malignant bone tumours.
Holzer G; Pfandlsteiner T; Koschat M; Noske H; Trieb K; Kotz R
Pediatr Blood Cancer; 2005 Feb; 44(2):163-6. PubMed ID: 15468309
[TBL] [Abstract][Full Text] [Related]
36. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
[TBL] [Abstract][Full Text] [Related]
37. Plasma metabonomics study of rheumatoid arthritis and its Chinese medicine subtypes by using liquid chromatography and gas chromatography coupled with mass spectrometry.
Gu Y; Lu C; Zha Q; Kong H; Lu X; Lu A; Xu G
Mol Biosyst; 2012 Apr; 8(5):1535-43. PubMed ID: 22419152
[TBL] [Abstract][Full Text] [Related]
38. Metabonomic profiling of liver metabolites by gas chromatography-mass spectrometry and its application to characterizing hyperlipidemia.
Gu S; A J; Wang G; Zha W; Yan B; Zhang Y; Ren H; Cao B; Liu L
Biomed Chromatogr; 2010 Mar; 24(3):245-52. PubMed ID: 19606418
[TBL] [Abstract][Full Text] [Related]
39. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer.
Ikeda A; Nishiumi S; Shinohara M; Yoshie T; Hatano N; Okuno T; Bamba T; Fukusaki E; Takenawa T; Azuma T; Yoshida M
Biomed Chromatogr; 2012 May; 26(5):548-58. PubMed ID: 21773981
[TBL] [Abstract][Full Text] [Related]
40. The metabonomic signature of celiac disease.
Bertini I; Calabrò A; De Carli V; Luchinat C; Nepi S; Porfirio B; Renzi D; Saccenti E; Tenori L
J Proteome Res; 2009 Jan; 8(1):170-7. PubMed ID: 19072164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
